Pharmacological Approach to Non-Responsive Schizophrenia

Wilson, William H.

Abstract

Funding Agency

• Agency: National Institute of Health (NIH)
• Institute: National Institute of Mental Health (NIMH)
• Type: First Independent Research Support & Transition (FIRST) Awards (R29)
• Project #: 1R29MH046700-01
• Application #: 3475467
• Study Section: Treatment Development and Assessment Research Review Committee (TDA)
• Project Start: 1989-09-01
• Project End: 1993-08-31
• Budget Start: 1989-09-01
• Budget End: 1990-08-31
• Support Year: 1
• Fiscal Year: 1989

Institution

• Name: Oregon Health and Science University
• Type: Schools of Medicine
• DUNS #: 009584210
• City: Portland
• State: OR
• Country: United States
• Zip Code: 97239

Publications

Wilson, W H (1996) Time required for initial improvement during clozapine treatment of refractory schizophrenia. Am J Psychiatry 153:951-2

Wilson, W H; Claussen, A M (1995) 18-month outcome of clozapine treatment for 100 patients in a state psychiatric hospital. Psychiatr Serv 46:386-9

Wilson, W H (1995) Do anticonvulsants hinder clozapine treatment? Biol Psychiatry 37:132-3

Wilson, W H; Claussen, A M (1994) Seizures associated with clozapine treatment in a state hospital. J Clin Psychiatry 55:184-8

Wilson, W H (1993) Addition of lithium to haloperidol in non-affective, antipsychotic non-responsive schizophrenia: a double blind, placebo controlled, parallel design clinical trial. Psychopharmacology (Berl) 111:359-66

Schalk, D C; Wilson, W H (1993) Impact of clozapine on medication use in a state hospital. Hosp Pharm 28:647-53

Wilson, W H (1992) Clinical review of clozapine treatment in a state hospital. Hosp Community Psychiatry 43:700-3